Koyfin Home > Directory > Health Care > Abbott Laboratories > EBITDA

Abbott Laboratories EBITDA Chart (ABT)

Abbott Laboratories annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Abbott Laboratories EBITDA for the quarter ending September 09, 2020 was $2,255m a 0.71% increase of 16m year over year
  • Abbott Laboratories EBITDA for the last 12 months ending September 09, 2020 was $7,823m a -1.10% decrease of -86m year over year
  • Abbott Laboratories Annual EBITDA for 2019 was $7,909m a 8.96% increase of 709m from 2018
  • Abbott Laboratories Annual EBITDA for 2018 was $7,200m a 17.26% increase of 1,243m from 2017
  • Abbott Laboratories Annual EBITDA for 2017 was $5,957m a 23.30% increase of 1,388m from 2016
Other Income Statement Metrics:
  • Abbott Laboratories Net Income for the quarter ending December 12, 2018 was $654m a 36.09% increase of 236m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT EBITDA Data

09/2020$2,255m
06/2020$1,552m
03/2020$1,666m
12/2019$2,239m
09/2019$2,007m
06/2019$2,013m
03/2019$1,549m
12/2018$2,078m
09/2018$1,849m
06/2018$1,775m

Annual ABT EBITDA Data

2019$7,909m
2018$7,200m
2017$5,957m
2016$4,569m
2015$4,389m
2014$4,397m
2013$3,864m
2012$4,285m
2011$4,719m
2010$9,664m